Feed Preview

Breast Cancer: Chemo-Resistance

Breast Cancer: Chemo-Resistance diagram by David A. Litman, Shutterstock
David A. Litman, Shutterstock

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Top 20 most recent papers
Breast Cancer Research and Treatment

HER2 borderline is a negative prognostic factor for primary malignant breast cancer

Breast Cancer Research and TreatmentApril 3, 2020
Atanu BhattacharjeeShilpee Dutt
2
Breast Cancer Research and Treatment

The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer

Breast Cancer Research and TreatmentApril 2, 2020
Jan J JobsenEster Siemerink
Breast Cancer Research and Treatment

Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer

Breast Cancer Research and TreatmentApril 2, 2020
Yvonne BrandbergSwedish Breast Cancer Group, the Austrian Breast, Colorectal Cancer Study Group, the German Breast Cancer Group
1
Breast Cancer Research and Treatment

Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience

Breast Cancer Research and TreatmentApril 3, 2020
Ingeborg J H VriensVivianne C G Tjan-Heijnen
Breast Cancer Research and Treatment

Metformin is distributed to tumor tissue in breast cancer patients in vivo: A 11 C-metformin PET/CT study

Breast Cancer Research and TreatmentApril 3, 2020
Elias Immanuel Ordell SundelinNiels Jessen
2
Breast Cancer Research and Treatment

Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?

Breast Cancer Research and TreatmentApril 3, 2020
Whitney L DoLauren E McCullough
Breast Cancer Research and Treatment

Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma

Breast Cancer Research and TreatmentApril 1, 2020
Wei LiuZhenzhen Wang
1
Drug Metabolism and Disposition : the Biological Fate of Chemicals

Epigenetic Regulation of MDR1 and BCRP Transporters by HDAC Inhibition

Drug Metabolism and Disposition : the Biological Fate of ChemicalsMarch 21, 2020
Dahea YouLauren M Aleksunes
1
Breast Cancer Research and Treatment

Breast implant-associated anaplastic large cell lymphoma: emotional impact and guidelines for psychological support

Breast Cancer Research and TreatmentApril 2, 2020
Serena OliveriGabriella Pravettoni
3

See more papers from this feed

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

© 2020 Meta ULC. All rights reserved
/feed-previews/breast-cancer-chemo-resistance/82d7d105-0cf8-4832-8e54-dfc4ae3b27fb